Clinical Trial Update: Artery Elasticity After Switch From Epzicom to Truvada [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating arterial elasticity after switching from Epzicom to Truvada in HIV infection; the study was terminated and results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epzicom (abacavir/lamivudine)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Hennepin Healthcare Research Institute | Conditions: HIV Infections | Phase 4 | Status: TERMINATED | Results posted: 2012-03-23